DRIO Stock UPDATES Labstyle (DRIO) 0.1470 09/11/2014 18:56:1

New Post Public Reply Private Reply Replies (0) Message Board

Sep 11, 2014 at 7:56 PM

Labstyle (DRIO) 0.1470 $DRIO

OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc.
PR Newswire Europe - Tue Aug 19, 10:11AM CDT
LONDON, August 19, 2014 /PRNewswire/ --

LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
PR Newswire - Fri Aug 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three and six months period ending June 30, 2014. The company also presented an overview of results of the Dario(TM) smart meter soft launch, recent corporate achievements and anticipated milestones for the remainder of 2014.

LabStyle Innovations Announces the Initial Launch of the Dario(TM) Diabetes Management Solution for Android Devices
PR Newswire - Thu Jul 31, 8:50AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company has released the Dario(TM) Diabetes Management App for Android smartphone users. The mobile application will have the same user interface and features as the iOS Dario(TM) Application and will be available in select soft launch markets, including the United Kingdom and New Zealand.

LabStyle Innovations wins Israeli Ministry of Health's approval to market the Dario Smart Meter to people living with diabetes in Israel
M2 - Tue Jul 29, 6:09AM CDT
Diabetes management company LabStyle Innovations (Other OTC

RIO) disclosed on Monday the receipt of the Israeli AMAR's approval for the marketing and sale of the Dario Smart Meter in Israel.

LabStyle Innovations Receives Israeli Ministry of Health Approval for the Dario(TM) Smart Meter
PR Newswire - Mon Jul 28, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has received approval from the Israeli AMAR for the marketing and sale of the Dario(TM) Smart Meter in Israel. The Israeli AMAR is a unit in the Ministry of Health and is responsible for certification of all activities concerning medical devices import, sale and export and is a precondition for the sale of medical devices in Israel.

LabStyle Innovations Corp.'s CEO Erez Raphael Interviewed by The Life Sciences Report
Marketwire - Thu Jul 17, 8:25AM CDT
Having a chronic disease like diabetes engenders a sense of isolation that hasn't been adequately addressed by technology until now. With Dario, LabStyle Innovations Corp. (OTCQB: DRIO) has created a device that not only provides vital medical information to a diabetic patient in real time, but also connects that patient to a community of care providers, family, and online resources. In this interview with The Life Sciences Report, LabStyle President and CEO Erez Raphael describes how the Dario software platform could provide sufferers of other chronic diseases with the benefits of real-time data and community as well.

LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors
PR Newswire - Thu Jul 10, 11:00AM CDT
LabStyle Innovations Corp. (OTCQB

RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors.

LabStyle Innovations to distribute its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical
M2 - Thu Jul 10, 7:35AM CDT
LabStyle Innovations (OTCQB

RIO), a mobile health company that provides laboratory-testing products, reported on Wednesday the launch of an exclusive distribution agreement for its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical.

LabStyle Innovations to Commence Sales of Dario(TM) in the Netherlands
PR Newswire - Wed Jul 09, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company is increasing its market reach by entering into an agreement with Viper Medical for exclusive distribution of the Dario(TM) Smart Meter, test strips and lancets in the Netherlands.

Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:35AM CDT
Hansen Medical one such stock considered to drop as it has witnessed a significant price decline and has seen negative earnings

LabStyle Innovations signs strategic distribution agreement in Canada for Dario Smart Meter, test strips and lancets
M2 - Mon Jun 30, 2:13AM CDT
Patented technolgy company LabStyle Innovations (Other OTC

RIO) reported on Friday the launch a strategic distribution agreement to grant the exclusive right to distribute the Dario Smart Meter, test strips and lancets in Canada to AutoControl Medical (ACM) .

LabStyle Innovations to Commence Sales of the Dario(TM) Smart Meter in North America
PR Newswire - Fri Jun 27, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has entered into a strategic distribution agreement with AutoControl Medical Inc. (ACM) that grants ACM the exclusive right to distribute the Dario(TM) Smart Meter, test strips and lancets in Canada.

LabStyle Innovations Awarded NHS Reimbursement Status in the United Kingdom for the Dario(TM) Smart Meter Strips and Lancets
PR Newswire - Wed Jun 25, 8:53AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO)announced today that it has been granted reimbursement status for strips and lancets to be utilized together with the patented Dario(TM) Smart Meter, effective September 1, 2014 in England, Wales, Scotland and Northern Ireland. Dario(TM) is a cloud-based, diabetes management solution which includes novel software applications combined with the stylish, 'all-in-one', pocket-sized, Dario Smart Meter which interfaces with a user's mobile device to form the overall Dario(TM) Diabetes Management Solution, allowing diabetics to monitor their blood sugars and other activities using their mobile devices.

LabStyle Innovations Reports Positive Results From the Initial Commercial Launch of Dario(TM) Smart Meter
PR Newswire - Tue Jun 17, 8:20AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today provided a positive update on the initial "soft" launch of the Dario(TM) Smart Meter in the company's initial target jurisdictions of the United Kingdom, Italy and New Zealand.

Renowned Diabetes Authority Dr. William Polonsky Joins LabStyle Innovations Medical/Scientific Advisory Board
PR Newswire - Wed Apr 02, 6:15AM CDT
LabStyle Innovations Corp. (OTCQB

RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Dr. William Polonsky to its Scientific/Medical Advisory Board.

IPOs and Transactions: March 17 - 21
PR Newswire - Mon Mar 24, 11:30AM CDT
There were 56 transactions filed with the SEC last week. Highlighted corporations and law firms include:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Grupo Simec 2026 Nine-Month Financial Surge Spells Change

Sharp Climb in Net Income Sparks Interest Buckle up, folks. Grupo Simec's nine-month results for 2026 are a mixed bag of surprises and steady flows. Let’s break it down: the net income skyrocketed by a whopping 428% compared to the same period last year—jumping from Ps. 763 million to Ps. 4,028 million. That's a solid leap, and it’s largely due to turning a hefty...

Cloopen Group's Private Transition: What Investors Should Know

Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...

LanguageLine AI App Earns Vizient Technology Kudos

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Freddy’s Joins Hershey For a Limited-Time Flavor Fest

The Sweet Collaboration We Didn't See Coming Well, folks, here's a tasty twist for you—Freddy's Frozen Custard & Steakburgers is cozying up to The Hershey Company to bring a sugar rush to our mundane lives. Starting Nov. 4, they're rolling out a limited-time series of treats so indulgent you'll want to skip straight to dessert. And if that wasn't enough, they're...

Bloomberg Law Integrates Docket Data with AI Platform

Bloomberg Law's Game-Changer for Legal Pros Here's something that'll make legal eagles perk up on this fine day: Bloomberg Law has rolled out a connector for Claude, marrying court dockets and litigation smarts to AI. Let's face it, the legal world always runs on precision and timing above all. So when an integration like this drops, it ain’t just a memo on the office...

AppLovin Faces Class Action: AI Growth Claims Under Fire

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Genedata's New ELN Transforms Biopharma R&D Workflows

Revolutionizing Research with a New Digital Tool Genedata, the brain behind enterprise software for drug discovery, has thrown a curveball into the world of biopharmaceutical research by launching a pioneering electronic lab notebook (ELN). This isn’t just another software update; it's a complete shift in how R&D workflows are structured and maintained. With an...

J.H. Strain & Sons' Asset Sale Seals a New Era

Texan Legacy Bows Out of the Asphalt Game Here's a fresh chapter in the world of road construction that'll have folks in the industry doing a double-take. Elder Bray & Bankler, a bigwig among corporate law circles, has been guiding this tale. They've shepherded J.H. Strain & Sons through selling off its asphalt manufacturing and construction assets to none other than...

Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...